1. Home
  2. ARMP

as 05-24-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Founded: N/A Country:
United States
United States
Employees: N/A City: LOS ANGELES
Market Cap: 92.9M IPO Year: N/A
Target Price: $7.00 AVG Volume (30 days): 16.9K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.27 EPS Growth: N/A
52 Week Low/High: $1.07 - $5.26 Next Earning Date: 05-07-2024
Revenue: $4,699,000 Revenue Growth: -7.28%
Revenue Growth (this year): 2.21% Revenue Growth (next year): -39.40%

ARMP Daily Stock ML Predictions

Share on Social Networks: